GlobeNewsWire
14 Oct 2026, 23:31 UTC · 1h ago
Unicycive Therapeutics, Inc. Class Action Reminder - Robbins LLP Encourages UNCY Investors to Contact the Firm About Their Rights
Impact · against what's priced in
The reminder of a class action lawsuit against Unicycive Therapeutics is a negative overhang but provides no new catalyst for the stock price. It reinforces existing legal risks associated with securities acquired between late 2025 and mid-2026.
- UNCY−0.10
No priced-in read yet





